
Sign up to save your podcasts
Or


How well do you understand the challenges that patients face with hormone receptor (HR)-positive/human epidermal growth factor receptor 2 (HER2)-negative early breast cancer with a high risk for recurrence?
Credit available for this activity expires: 12/15/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999101?ecd=bdc_podcast_libsyn_mscpedu
By Medscape4.3
2323 ratings
How well do you understand the challenges that patients face with hormone receptor (HR)-positive/human epidermal growth factor receptor 2 (HER2)-negative early breast cancer with a high risk for recurrence?
Credit available for this activity expires: 12/15/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999101?ecd=bdc_podcast_libsyn_mscpedu

320 Listeners

696 Listeners

495 Listeners

170 Listeners

101 Listeners

886 Listeners

13 Listeners

17 Listeners

291 Listeners

262 Listeners

3,330 Listeners

138 Listeners

1,152 Listeners

8,934 Listeners

196 Listeners

61 Listeners

8 Listeners

430 Listeners

313 Listeners